Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03571724 · ClinicalTrials.gov registry record · NA
A Study to Assess Changes in Cigarette Consumption During a Switch to Very Low Nicotine Cigarettes
A NA study, sponsored by 22nd Century Group.
- Completed
- Registry status
- NA
- Development phase
- 142
- Enrollment target
NCT03571724: Completed NA study, sponsored by 22nd Century Group.
NCT03571724 is a NA study that has completed, run by 22nd Century Group. The registered enrollment target is 142 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03571724, a NA study, has completed, sponsored by 22nd Century Group.
- COMPLETED
- Registry status
- NA
- Development phase
- 142 participants
- Enrollment target
Study Summary
This study evaluates the impact of switching from usual brand cigarettes to very low nicotine cigarettes on cigarette consumption, smoking behavior, and biomarkers of exposure.
Primary Outcome
Primary objective is to measure a change in cigarette consumption behavior before, during and after switching from usual brand to to VLN cigarettes. Subjects will record their cigarette consumption daily in an electronic diary. The baseline data were collected for participants at Week -1, and Week -1 data are reported per post-switch Arms/Group randomization (instead of pre-switch Arms/Group assignment).All 142 randomized subjects were included in the ITT population based on product use. Out of
Interventions
- OTHER Non-Menthol Very Low Nicotine Cigarettes
- OTHER Menthol Very Low Nicotine Cigarettes
- OTHER Subject's UB non-mentholated filtered cigarettes
- OTHER Subject's UB mentholated filtered cigarettes
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 142 participants |
| Start Date | 2018-06-28 |
| Est. Completion | 2019-03-08 |
| Phase | NA |
What the finished NCT03571724 record still lists
NCT03571724 is an interventional study that assigns participants to a tested intervention. The registered 142 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 4 interventions - of which Non-Menthol Very Low Nicotine Cigarettes is the first listed.
NCT03571724 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03571724 about?
NCT03571724 is a clinical study titled "A Study to Assess Changes in Cigarette Consumption During a Switch to Very Low Nicotine Cigarettes". This study evaluates the impact of switching from usual brand cigarettes to very low nicotine cigarettes on cigarette consumption, smoking behavior, and biomarkers of exposure.
What is the current status of trial NCT03571724?
This trial is currently completed. It is a NA study. The enrollment target is 142 participants. The study started on 2018-06-28. Estimated completion is 2019-03-08.
What interventions are being tested in trial NCT03571724?
The interventions under investigation include: Non-Menthol Very Low Nicotine Cigarettes (OTHER), Menthol Very Low Nicotine Cigarettes (OTHER), Subject's UB non-mentholated filtered cigarettes (OTHER), Subject's UB mentholated filtered cigarettes (OTHER).
Who is sponsoring clinical trial NCT03571724?
This trial is sponsored by 22nd Century Group, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03571724's enrollment target sits among peer trials
142 711th of 2000 higher than 1,289 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03933631 · 142 participants · Phase 3
Pilocarpine Use After Kahook Goniotomy
- NCT04938349 · 142 participants · NA
Dual Task Perturbation Training for OAwMCI
- NCT06117254 · 142 participants · NA
Hearing Aids for Veterans With Functional Hearing Difficulties
- NCT06463665 · 142 participants · Phase 2
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI